<div class="headers"><div>Figure 4. Mean percent change (95% Cis) from baseline to end point in plasma concentration of low-density lipoprotein cho­lesterol (LDL-C) for pooled ezetimibe/simvastatin (EZE/SIMVA) and pooled simvastatin (SIMVA) presented by sub­group. Numbers in parentheses indicate numbers for the pooled SIMVA and pooled EZE/SIMVA groups, respec­tively. HT = hypertension; DM = diabetes mellitus; BMI = body mass index; LDL-C = low-density lipoprotein cholesterol; CHD = coronary heart disease;TG = triglycerides; HDL-C = high-density lipoprotein cholesterol.</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<tbody>
<tr style='border-top: 2px solid grey;'>
<td style='border-top: 2px solid grey; border-bottom: 2px solid grey; text-align: left;'><p style="" class="">Figure 4. Mean percent change (95% Cis) from baseline to end point in plasma concentration of low-density lipoprotein cho­lesterol (LDL-C) for pooled ezetimibe/simvastatin (EZE/SIMVA) and pooled simvastatin (SIMVA) presented by sub­group. Numbers in parentheses indicate numbers for the pooled SIMVA and pooled EZE/SIMVA groups, respec­tively. HT = hypertension; DM = diabetes mellitus; BMI = body mass index; LDL-C = low-density lipoprotein cholesterol; CHD = coronary heart disease;TG = triglycerides; HDL-C = high-density lipoprotein cholesterol.</p></td>
</tr>
</tbody>
</table>
